CellSine

Andreas Vesaliusstraat 5 B301

3000 Leuven

BE

CellSine

Foundation date

11-2015

Sector

#Biotechnology / R&D Services

Subsector

CellSine was founded in 2015 as a spin-off company from KU Leuven and VUB. We offer instruments and services based on advanced electrochemical impedance spectroscopy for drug discovery and other biomedical applications. The proprietary I-series devices allow you to perform broad-spectrum impedance measurements. Such measurements enable the detection of a wide range of biological phenomena without the use of chemical labels.The latter aspect enables you to design your own high content analyses of living cells in a matter of weeks. The “light” structure of the resulting “big”data is ideal for ultimate exploration with artificial intelligence methods, machine learning, and many other data processing tools.

Upcoming events

Latest news

  • Scipher Medicine and Galapagos sign collaboration in inflammatory bowel disease

    Thursday August 13th 2020

  • Bone Therapeutics receives EUR 1.0 million to advance ongoing JTA-004 phase III knee osteoarthritis study

    Thursday August 13th 2020

  • BISC Global opens in Switzerland

    Wednesday August 12th 2020